HomeFinTechTelix Pharmaceuticals: Acquires Optimal Tracers

Telix Pharmaceuticals: Acquires Optimal Tracers

Date:

UK Tribunal Rules Visa and Mastercard Interchange Fees Breach Competition Law

Landmark decision finds payment giants’ multilateral interchange fees unlawful,...

UK Tribunal Rules Visa and Mastercard Fees Violate Competition Law

Landmark Decision Could Reshape Payment Processing Landscape Highlights: The UK...

Belgium Prosecutors Investigate Worldline Local Unit for Potential Misconduct

An In-Depth Look into the Probe and Its Implications...

Telix Pharmaceuticals Acquires Optimal Tracers

  • Telix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acquire radiochemistry specialist Optimal Tracers
  • The company believes the acquisition will “bolster” its in-house radiochemistry development capability by adding a highly-skilled team and establishing a US-based lab
  • Telix will also own Optimal Tracer’s facility, which has a radiation and pharmaceutical manufacturing licence to support pre-clinical and clinical research
  • Optimal Tracer’s CEO, Ruth Tesar, says she’s looking forward to providing Telix with the radiochemistry knowledge and experience to contribute to its future success
  • TLX shares are trading at $6.78 at 2:49 pm AEDT
Exit mobile version